Evommune, Inc. Common Stock (EVMN)

Operating Cash Flow Growth

22.48%

Quarterly · Period ending:

EVMN logo

EVMN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported22.48%
EVMN Quarterly Cash from Operations YoY % (-394.80% → 22.48%)
High-resolution chart · PNG

EVMN operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
22.4817%
-15.0801%
9.7936%
63.263%
-203.8256%
-394.8033%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.